New Zealand changes policy on antenatal HIV screening:
This article was originally published in Clinica
New Zealand is to move towards routine antenatal HIV screening in line with the practice in Australia, the UK and elsewhere. In accordance with recommendations in the National Health Committee's "HIV screening in pregnancy" report 2004, the new policy will be piloted in an area of Auckland (Waikato) before it is implemented nationwide. The change in policy follows criticism that the current approach, of testing only high-risk patients, is being poorly implemented. New Zealand has a low but rising incidence of HIV.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.